Ladenburg Thalmann Financial Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$178K	Sell	36,094 -7,373	-17%	-$25.6K	﹤0.01%	2592
2019 Q3	$126K	Buy	43,467 +6,965	+19%	+$24.3K	﹤0.01%	2781
2019 Q2	$258K	Sell	36,502 -8,328	-19%	-$85.1K	﹤0.01%	2270
2019 Q1	$641K	Sell	44,830 -280	-0.6%	-$3.7K	﹤0.01%	1492
2018 Q4	$669K	Buy	45,110 +45,085	+180,340%	+$812K	0.01%	1325
2018 Q3	$1K	Buy	+25	New	+$526	﹤0.01%	4958

Other funds holding AMRX

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ladenburg Thalmann Financial Services's AMRX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Amneal Pharmaceuticals (AMRX) stake by 17% in Q4 2019, selling an estimated $25.6K and leaving 36,094 shares worth $178K. The position accounts for ﹤0.01% of the portfolio, ranked #2592.

Ladenburg Thalmann Financial Services first reported a position in AMRX in Q3 2018 and has held it in 6 quarters since. The position peaked at $669K in Q4 2018. 129 funds tracked by Wall St. Rank hold AMRX as of Q4 2019.

Ladenburg Thalmann Financial Services held 36,094 shares of Amneal Pharmaceuticals worth $178K as of Q4 2019.
Ladenburg Thalmann Financial Services sold 7,373 Amneal Pharmaceuticals shares in Q4 2019, an estimated $25.6K.
Amneal Pharmaceuticals made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #2592 holding.
Ladenburg Thalmann Financial Services first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 6 quarters since.
Ladenburg Thalmann Financial Services's Amneal Pharmaceuticals position peaked at $669K in Q4 2018.
129 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.